. Author manuscript; available in PMC: 2020 Apr 20.

Published in final edited form as: J Nephrol. 2019 Sep 5;33(2):307–316. doi: 10.1007/s40620-019-00640-z

Table 3.

The distribution of the groups of patients with IgAN, ANCA-associated vasculitis, and healthy controls

Groups 1 – 4: IgAN	Number of subjects
Group 1: PU <1 g/d, normal renal function	8
Group 2: PU >1 g/d, normal renal function	11
Group 3: renal insufficiency: S-Cr > 150, PU >1 g/d	10
Group 4: renal insufficiency: S-Cr > 150, PU <1 g/d	5
Group 5: ANCA-associated vasculitis	7
Group 6: Controls	15

Abbreviations: IgAN, IgA nephropathy; Four groups of patients with IgAN: 1. normal renal function with proteinuria <1 g/day at the time of renal biopsy, 2. normal renal function with proteinuria >1 g/day at the time of renal biopsy, 3. renal insufficiency (serum creatinine >150 μmol/l) and proteinuria >1 g/day at the time of renal biopsy, 4. renal insufficiency (serum creatinine >150 μmol/l) and proteinuria <1 g/day at the time of renal biopsy; PU, proteinuria (g/day); S-Cr, serum creatinine (μmol/l).